Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LPCN 1144 Open-Label Extension in NASH
NCT04685993Phase 2Completed
- Sponsor
- Lipocine Inc
- Start
- Nov 2020
- Primary completion
- Mar 2022
- Modality
- Hormone, Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of testosterone undecanoate in Nonalcoholic steatohepatitis (NASH), sponsored by Lipocine Inc. Started Nov 2020; status: completed.
02
Drugs
testosterone undecanoate
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT04685993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04685993.